“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: A-120 THE IMPORTANCE OF A LOW LIMIT OF DETECTION FOR COAGULATION FACTOR ASSAYS: FIX, AN EXAMPLE IN DAILY PRACTICE
A-120 THE IMPORTANCE OF A LOW LIMIT OF DETECTION FOR COAGULATION FACTOR ASSAYS: FIX, AN EXAMPLE IN DAILY PRACTICE
Reviews
There are no reviews yet.
Be the first to review “Article: A-120 THE IMPORTANCE OF A LOW LIMIT OF DETECTION FOR COAGULATION FACTOR ASSAYS: FIX, AN EXAMPLE IN DAILY PRACTICE” Cancel reply
Reviews
There are no reviews yet.